Norway's Enova hands $114mn for hydrogen production    Gold prices in Egypt on June 29    World Bank to provide Egypt $500 million to enhance food security – minister    Saudi citizens could enter Schengen countries visa-free    Egypt's Petrojet returns to Libyan oil sector after 11 years    Cemex, VeryNile sign deal for Egypt's Nile River    NATO remarks Egypt's role in maintaining stability in Middle East and Africa    Congo needs Egypt's expertise to diversify its economy – FPI official    Dostarlimab drug cures rectal cancer patient 100%, trials show    Egypt: A royal train turns into a new tourism attraction    Conclusions and Recommendations of the 1st edition of Africa Health ExCon    For the first time John Legend to perform in Egypt    Egypt discovers newly treasure trove of ancient artifacts at Saqqara Necropolis    Noura Al-Mutair – first Gulf female boxer in World Championships    Liverpool fans: "You'll Never Walk Alone" to Cristiano Ronaldo    Egypt to play key role in integrating water, climate issues globally – World Bank official    Egypt's telecoms regulator announces working hours for holy month of Ramadan    Maha karara joins AAIB as Head of Corporate Communications, Sustainability    Egypt works on charting cooperation strategies with international institutions for 5 years: Al-Mashat    Over 2.4 million newborns examined for hearing impairment: Health Ministry    Netflix releases trailer of Arab adaption of 'Perfect Strangers' film    Balqees to headline concert celebrating launch of streaming giant LIVENow in MENA    Sawsan Badr to be honoured at Aswan Women Film Festival    MP Abdel Hady Al-Qasby calls government to facilitate and support NGOs    Al-Sisi follows up on 'Great Transfiguration Project' in St. Catherine    Cairo, London stress need to strengthen cooperation to face climate change    Foreigners account for 22.6% of Egypt's T-bills issuances in 1H 2021: CBE    Egypt's ambassador to Italy passes away    Egypt confirms readiness to help African countries face terrorism and extremism    An estimated 235 million people needed humanitarian assistance and protection in 2021, an increase of 40% compared to 2020: IOM Egypt    Egypt, DRC discuss water cooperation during WYF    Egypt, DR Congo discuss boosting bilateral cooperation during WYF    Cameroonian police probe assault on three Algerian journalists covering AFCON    Pharaohs start AFCON 2021 campaign with fierce clash against Nigeria    Foreign Ministry opens capacity building course for French-speaking African diplomats    Egypt's trade with Nile basin countries climbs 26% y-o-y in 9 months    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Egypt reserves doses of anticipated Pfizer and Oxford trial coronavirus vaccines – minister
Published in Amwal Al Ghad on 11 - 11 - 2020

Egypt has reserved doses of a potential coronavirus vaccine developed by Pfizer Inc and BioNTech that would cover up to 20 percent of the country's needs, its health minister said in a statement on Tuesday.
Hala Zayed said the country has also secured doses of a promising British vaccine developed by AstraZeneca and Oxford University that will meet around 30 percent of the country's needs.
On Monday, U.S. pharmaceutical Pfizer and its German partner BioNTech announced their Covid-19 vaccine candidate, BNT162b2 is more than 90 percent effective based on results of initial third-phase a large-scale trial.
Pfizer revealed that up to 1.3 billion doses of the vaccine could be produced in 2021.
"The mRNA-based vaccine candidate demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study," Pfizer said in a statement.
Later in the day, the World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus hailed Pfizer and BioNTech‘s announcement on the efficacy of their coronavirus vaccine as ‘encouraging'.
"We welcome the encouraging vaccine news from Pfizer and BioNTech Group and salute all scientists and partners around the who are developing new safe, efficacious tools to beat COVID19." Ghebreyesus tweeted.
While AstraZeneca-Oxford's vaccine, which has been shown in an early trial to prompt a protective immune response, is expected to be rolled out by the end of the year.
Zayed added that as many as eleven coronavirus vaccines have reached advanced stages, and Egypt is participating in the clinical trials of two of them.
In July, Egypt was selected by China to serve as a future African hub for manufacturing its possible coronavirus vaccines, if Beijing develops one.
Trials of two China-made vaccines are being carried out in Egypt in cooperation with the Chinese government and other drugmakers.


Clic here to read the story from its source.